Article
Mutations in DNA binding domain of p53 impede RSL1D1-p53 interaction to escape from degradation in human colorectal cancer cells.
Experimental cell research - 1 Aug 2022
Ding Li, Zhao Chenhong, Xu Yujie, Zhang Zhiping, Nie Yesen, Liao Kai, Chen Yuerou, Tu Beibei, Zhang Xinyue
Abstract excerpt
Different from the nucleolus-specific localization in some types of cancer cells, ribosomal L1 domain-containing protein 1 (RSL1D1) distributes throughout the nucleus in human colorectal cancer (CRC) cells. RSL1D1 directly interacts with DNA binding domain (aa 93-292) of wild-type p53 (p53-WT) and thereby recruits p53 to HDM2. The ensuing formation of RSL1D1/HDM2/p53 complex enhances p53 ubiquitination and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
